Eton Pharmaceuticals, Inc. (ETON)
USD 11.91
(-5.78%)
USD 11.91
(-5.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 6.81 Million | 4.82 Million | -4.72 Million | -22.34 Million | -18.02 Million | -8.14 Million |
| Net Income | -936 Thousand | -9.02 Million | -1.95 Million | -27.97 Million | -18.32 Million | -12.74 Million |
| Depreciation & Amortization | 901 Thousand | 1.77 Million | 462 Thousand | 651 Thousand | 447 Thousand | 63 Thousand |
| Deferred income taxes | - | - | -546 Thousand | - | - | - |
| Stock-based compensation | 3.13 Million | 4.21 Million | 3.38 Million | 2.57 Million | 1.88 Million | 1.85 Million |
| Change in working capital | 3.59 Million | 7.72 Million | -6.21 Million | 1.01 Million | -2.05 Million | 99 Thousand |
| Other non-cash items | 6.91 Million | 127 Thousand | 148 Thousand | 1.38 Million | 16 Thousand | 2.58 Million |
| Investing Cash Flow | -775 Thousand | -2.78 Million | -2.55 Million | -50 Thousand | -1.84 Million | -236 Thousand |
| Investments in PPE | -775 Thousand | -2.78 Million | -3.25 Million | -50 Thousand | -1.84 Million | -236 Thousand |
| Acquisitions | - | - | 700 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -775 Thousand | -2.75 Million | -2.55 Million | - | -750 Thousand | - |
| Financing Cash Flow | -957 Thousand | -134 Thousand | 391 Thousand | 31.62 Million | 5.2 Million | 21.96 Million |
| Debt repayment | -1.15 Million | -385 Thousand | -150 Thousand | -2.47 Million | -4.75 Million | - |
| Dividends payments | - | - | - | - | - | -1.04 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 198 Thousand | 251 Thousand | 541 Thousand | 28.78 Million | 226 Thousand | 22.8 Million |
| Other Financing Activities | 198 Thousand | 251 Thousand | 541 Thousand | 5.31 Million | 9.72 Million | 205 Thousand |
| Accounts receivables | -1.55 Million | 3.61 Million | -5.42 Million | 425 Thousand | -473 Thousand | - |
| Accounts payables | 53 Thousand | -8000.00 | -570 Thousand | 1.76 Million | -377 Thousand | 413 Thousand |
| Inventory | -354 Thousand | -7000.00 | 692 Thousand | -862 Thousand | -380 Thousand | - |
| Other working capital | 5.45 Million | 4.11 Million | -910 Thousand | -320 Thousand | -827 Thousand | -314 Thousand |
| Cash at beginning of period | 16.3 Million | 14.4 Million | 21.29 Million | 12.06 Million | 26.73 Million | 13.15 Million |
| Cash at end of period | 21.38 Million | 16.3 Million | 14.4 Million | 21.29 Million | 12.06 Million | 26.73 Million |
| Capital Expenditure | -775 Thousand | -2.78 Million | -3.25 Million | -50 Thousand | -1.84 Million | -236 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 5.08 Million | 1.89 Million | -6.88 Million | 9.22 Million | -14.66 Million | 13.57 Million |
| Free Cash Flow | 6.04 Million | 2.03 Million | -7.98 Million | -22.39 Million | -19.87 Million | -8.38 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.04 Million | -811 Thousand | -936 Thousand | -2.25 Million | -579 Thousand | 4.55 Million |
| Depreciation & Amortization | 279 Thousand | 252 Thousand | 901 Thousand | 275 Thousand | 202 Thousand | 211 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 840 Thousand | 821 Thousand | 3.13 Million | 750 Thousand | 730 Thousand | 785 Thousand |
| Change in working capital | 3.13 Million | -2.76 Million | 3.59 Million | 1.59 Million | 491 Thousand | 1.51 Million |
| Other non-cash items | 1.95 Million | 3.17 Million | 6.91 Million | 998 Thousand | 29 Thousand | 32 Thousand |
| Investing Cash Flow | - | -1.88 Million | -775 Thousand | -775 Thousand | - | - |
| Investments in PPE | - | -1.88 Million | -775 Thousand | -775 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -1.86 Million | -775 Thousand | -775 Thousand | - | - |
| Financing Cash Flow | -216 Thousand | -378 Thousand | -957 Thousand | -294 Thousand | -368 Thousand | -246 Thousand |
| Debt repayment | -385 Thousand | -385 Thousand | -1.15 Million | -385 Thousand | -385 Thousand | -385 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -90 Thousand | - | - |
| Common Stock Issuance | 169 Thousand | 7000.00 | 198 Thousand | -90 Thousand | 17 Thousand | 139 Thousand |
| Other Financing Activities | 169 Thousand | -378 Thousand | 198 Thousand | 181 Thousand | 17 Thousand | -246 Thousand |
| Accounts receivables | -633 Thousand | -829 Thousand | -1.55 Million | 84 Thousand | -411 Thousand | -210 Thousand |
| Accounts payables | -130 Thousand | 414 Thousand | 53 Thousand | 105 Thousand | -589 Thousand | 1.06 Million |
| Inventory | 250 Thousand | -1.4 Million | -354 Thousand | 140 Thousand | -235 Thousand | -379 Thousand |
| Other working capital | 3.64 Million | -937.99 Thousand | 5.45 Million | 1.26 Million | 1.72 Million | 1.03 Million |
| Cash at beginning of period | 16.65 Million | 21.38 Million | 16.3 Million | 22.07 Million | 21.56 Million | 14.7 Million |
| Cash at end of period | 17.69 Million | 16.65 Million | 21.38 Million | 21.38 Million | 22.07 Million | 21.56 Million |
| Capital Expenditure | - | -1.88 Million | -775 Thousand | -775 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.03 Million | -4.73 Million | 5.08 Million | -682 Thousand | 504 Thousand | 6.85 Million |
| Free Cash Flow | 1.25 Million | -4.35 Million | 6.04 Million | -388 Thousand | 873 Thousand | 7.1 Million |
DUST
PDES
SQZB
MGLUY
UGHB
2852